These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9241318)

  • 1. Cost-effectiveness of strategies used in the evaluation of pregnancies complicated by elevated maternal serum alpha-fetoprotein levels.
    Lenke R
    Obstet Gynecol; 1997 Aug; 90(2):317-8. PubMed ID: 9241318
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of strategies used in the evaluation of pregnancies complicated by elevated maternal serum alpha-fetoprotein levels.
    Nadel AS; Norton ME; Wilkins-Haug L
    Obstet Gynecol; 1997 May; 89(5 Pt 1):660-5. PubMed ID: 9166296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High maternal serum alpha-fetoprotein levels during the 2nd trimester of pregnancy: diagnostic approach.
    Periti E; Cariati E; Brizzi L; Nannini R; Paladini S
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):81-4. PubMed ID: 2480430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-benefit analysis of targeted ultrasonography for prenatal detection of spina bifida in patients with an elevated concentration of second-trimester maternal serum alpha-fetoprotein.
    Vintzileos AM; Ananth CV; Fisher AJ; Smulian JC; Day-Salvatore D; Beazoglou T; Knuppel RA
    Am J Obstet Gynecol; 1999 May; 180(5):1227-33. PubMed ID: 10329882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of aneuploidy and unexplained elevated maternal serum alpha-fetoprotein.
    Hiett AK; Callaghan CM; Brown HL; Golichowski AM; Heerema NA
    J Perinatol; 1998; 18(5):343-6. PubMed ID: 9766408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cost-effectiveness analysis of prenatal screening strategies for Down syndrome.
    Odibo AO; Stamilio DM; Nelson DB; Sehdev HM; Macones GA
    Obstet Gynecol; 2005 Sep; 106(3):562-8. PubMed ID: 16135588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal maternal serum alpha fetoprotein and pregnancy outcome.
    Zarzour SJ; Gabert HA; Diket AL; St Amant M; Miller JM
    J Matern Fetal Med; 1998; 7(6):304-7. PubMed ID: 9848697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alpha-fetoprotein and chromosome aberrations: what else? Results of a prospective study concerning 15,533 pregnancies].
    Marguerat P; Weihs D; Pescia G; Gaide AC; Addor MC; Nguyen The H
    Rev Med Suisse Romande; 1993 Apr; 113(4):273-6. PubMed ID: 7684851
    [No Abstract]   [Full Text] [Related]  

  • 9. Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience.
    Anfuso S; Soncini E; Bonelli P; Piantelli G; Gramellini D
    Acta Biomed; 2007 Dec; 78(3):214-9. PubMed ID: 18330082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal serum biochemical screening for pregnancy complications other than aneuploidy.
    Pahal GS; Jauniaux E
    Curr Opin Obstet Gynecol; 1997 Dec; 9(6):379-86. PubMed ID: 9425582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexplained, elevated maternal serum alpha-fetoprotein suggesting blunt abdominal trauma in pregnancy. A case report.
    Romem A; Romem Y
    J Reprod Med; 2003 Jul; 48(7):566-8. PubMed ID: 12953335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amniocentesis for twin pregnancies: is alpha-fetoprotein useful in confirming that the two sacs were sampled?
    Delisle MF; Brosseuk L; Wilson RD
    Fetal Diagn Ther; 2007; 22(3):221-5. PubMed ID: 17228163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal Down syndrome screening: a cost effectiveness analysis of alternative screening programs.
    Cusick W; Vintzileos AM
    J Matern Fetal Med; 1999; 8(6):243-8. PubMed ID: 10582856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Karyotyping amniotic fluids from patients with high serum alpha-fetoprotein.
    Bobrow M; Lindenbaum RH; Seabright M; Gregson N
    Lancet; 1981 Mar; 1(8220 Pt 1):606-7. PubMed ID: 6163053
    [No Abstract]   [Full Text] [Related]  

  • 15. Maternal midtrimester free beta-HCG and AFP serum levels in spontaneous singleton pregnancies complicated by gestational diabetes mellitus, pregnancy-induced hypertension or obstetric cholestasis.
    Räty R; Anttila L; Virtanen A; Koskinen P; Laitinen P; Mörsky P; Tiitinen A; Martikainen H; Ekblad U
    Prenat Diagn; 2003 Dec; 23(13):1045-8. PubMed ID: 14691989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-fetoprotein detection of neural tube defects and the impact of standard ultrasound.
    Dashe JS; Twickler DM; Santos-Ramos R; McIntire DD; Ramus RM
    Am J Obstet Gynecol; 2006 Dec; 195(6):1623-8. PubMed ID: 16769022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of alpha-fetoprotein during pregnancy and early infancy in normal and disease states.
    Mizejewski GJ
    Obstet Gynecol Surv; 2003 Dec; 58(12):804-26. PubMed ID: 14668662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproductive genetics and today's patient options: prenatal diagnosis.
    Willner JP
    Mt Sinai J Med; 1998 May; 65(3):173-7. PubMed ID: 9615567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prenatal presentation of congenital erythropoietic porphyria: report of two siblings with elevated maternal serum alpha-fetoprotein.
    Lazebnik N; Lazebnik RS
    Prenat Diagn; 2004 Apr; 24(4):282-6. PubMed ID: 15065102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal serum alpha-fetoprotein levels in congenital nephrotic syndrome carrier pregnancies.
    Carrera M; Kestilä M; de la Iglesia C; Ruiz J; Serra B; Baraibar R
    Prenat Diagn; 1999 May; 19(5):489-90. PubMed ID: 10360523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.